Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Prognostic Parameters in Adults with Acute Lymphoblastic Leukemia at Second Complete Response

Caner Saygin, MD, Nikolaos Papadantonakis, MD PhD, Ryan D Cassaday, MD, Michaela Liedtke, MD, Katrina Fischer, MD, Tamara J. Dunn, MD, Bhumika Patel, MD, Sean Hobson, Cassie Zimmerman, Jaime Lynn Fensterl, MS, MBA, Ronald M. Sobecks, MD, Matt Kalaycio, MD FACP, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD, PhD, M.P.H., Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD

Blood (2016) 128 (22): 1603.

https://doi.org/10.1182/blood.V128.22.1603.1603

Published: 2016

Journal Articles

Assessment of Human Leukocyte Antigen (HLA) Type on Outcomes of Allogeneic Transplant for Chronic Lymphocytic Leukemia (CLL)

Brian T. Hill, MD PhD, Kwang Woo Ahn, PhD, Zhen-Huan Hu, MPH, Matt Kalaycio, MD FACP, Richard T. Maziarz, MD, Jorge E. Cortes, MD, Edwin Alyea, MD, Uday R. Popat, MD, Ronald M. Sobecks, MD, Wael Saber, MD MS

Blood (2016) 128 (22): 2256.

https://doi.org/10.1182/blood.V128.22.2256.2256

Published: 2016

Journal Articles

Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide (Bu/Cy/VP) Produces Comparable Outcomes to 4-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)

Brian T. Hill, MD PhD, Lisa A. Rybicki, MS, Catherine Weber, PharmD, Deepa Jagadeesh, MD MPH, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Hien K. Liu, MD, Robert M. Dean, MD, Ronald M. Sobecks, MD, Brad Pohlman, MD, Steven Andresen, DO, Matt Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS

Blood (2015) 126 (23): 1987.

https://doi.org/10.1182/blood.V126.23.1987.1987

Published: 2015

Journal Articles

Prognostic Impact of Molecular Mutations in AML at First Relapse

Anjali S. Advani, MD, Paul Elson, PhD, Valeria Visconte, PhD, Jennifer S. Carew, PhD, Jaime Fensterl, Bartlomiej Przychodzen, MSc, Mikkael A. Sekeres, MD MS, Cassandra M Hirsch, Alek Nielsen, John Desamito, Hetty E. Carraway, MD MBA, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Sudipto Mukherjee, MD PhD, Ronald M. Sobecks, MD, Matt Kalaycio, MD, Yogen Saunthararajah, MD, Jaroslaw P. Maciejewski, MD PhD

Blood (2015) 126 (23): 3825.

https://doi.org/10.1182/blood.V126.23.3825.3825

Published: 2015

Journal Articles

A Phase I Study of Ixazomib in Combination with Panobinostat and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Frederic J. Reu, MD, Jason Valent, MD, Ehsan Malek, MD, Ronald M. Sobecks, MD, Beth M Faiman, PhD RN, MSN, CNP, AOCN, Kimberly Hamilton, CNP, Jamie Elberson, RN, Sherry Fada, Hien K. Liu, MD, Christy Samaras, DO, Mitchell R. Smith, MD PhD

Blood (2015) 126 (23): 4221.

https://doi.org/10.1182/blood.V126.23.4221.4221

Published: 2015

Journal Articles

Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)

Blood (2015) 126 (23): 2536.

https://doi.org/10.1182/blood.V126.23.2536.2536

Published: 2015

Journal Articles

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes: A Center for International Blood and Marrow Transplant Registry (CIBMTR®) Study

Aaron T. Gerds, MD MS, Matt E. Kalaycio, MD, Kwang Woo Ahn, PhD, Zhen-Huan Hu, MPH, Edwin P. Alyea, MD, Uday R. Popat, MD, Ronald M. Sobecks, MD, Wael Saber, MD MS

Blood (2015) 126 (23): 2003.

https://doi.org/10.1182/blood.V126.23.2003.2003

Published: 2015

Journal Articles

Association of Donor Killer Immunoglobulin-like Receptor (KIR) Genotype with Outcome after HLA-Matched Related Donor Hematopoietic Cell Transplantation for AML

Ronald M. Sobecks, MD, Dawn Thomas, BS, Aiwen Zhang, PhD, Mostafa Mohammed Saleh, MD, Lisa Rybicki, MS, Melissa A Yurch, Hien K. Duong, MD, Aaron Gerds, MDMS, Betty K. Hamilton, MD, Robert M Dean, MD, Brian T. Hill, MD PhD, Rabi Hanna, MD, Brian J. Bolwell, MD, Matt E. Kalaycio, MD, Navneet S. Majhail, MD MS, Medhat Askar, MD PhD

Blood (2014) 124 (21): 2566.

https://doi.org/10.1182/blood.V124.21.2566.2566

Published: 2014

Journal Articles

A Prognostic Scoring System for Newly Diagnosed Adult Acute Lymphocytic Leukemia Patients

Mingjia Li, MD, Aziz Nazha, MD, Paul Elson, Sean Hobson, MA, Mikkael A. Sekeres, MD MS, Matt E. Kalaycio, MD, Ronald M. Sobecks, MD, Aaron Gerds, MDMS, Betty K. Hamilton, MD, Sudipto Mukherjee, MD MPH, Hetty E. Carraway, MD, Anjali S. Advani, MD

Blood (2014) 124 (21): 5252.

https://doi.org/10.1182/blood.V124.21.5252.5252

Published: 2014

Journal Articles

Prognostic Significance of Quality of Life in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Betty K. Hamilton, MD, Lisa Rybicki, MS, Donna M Abounader, Jane Dabney, LISW, Robert M Dean, MD, Hien K. Duong, MD, Brian T. Hill, MD PhD, Aaron Gerds, MDMS, Deepa Jagadeesh, MD MPH, Matt E. Kalaycio, MD, Christine Lawrence, LISW, Linda McLellan, LISW, Brad Pohlman, MD, Ronald M. Sobecks, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS

Blood (2014) 124 (21): 2637.

https://doi.org/10.1182/blood.V124.21.2637.2637

Published: 2014

Journal Articles

Efficacy of Standard Dose R-CHOP Alternating with R-HiDAC Followed By ASCT As Initial Therapy of Mantle Cell Lymphoma: Cleveland Clinic Experience

Danyu Sun, MD PhD, Brian T. Hill, MD PhD, Lisa Rybicki, MS, Basel Rouphail, MD, Robert M Dean, MD, Deepa Jagadeesh, MD MPH, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Ronald M. Sobecks, MD, Hien K. Duong, MD, Steven Andresen, DO, Navneet S. Majhail, MD MS, Brad Pohlman, MD, Matt E. Kalaycio, MD, Brian J. Bolwell, MD, Mitchell R. Smith, MD PhD

Blood (2014) 124 (21): 1730.

https://doi.org/10.1182/blood.V124.21.1730.1730

Published: 2014

Journal Articles

Long Term Outcomes after Autologous Stem Cell Transplantation for Peripheral T Cell Lymphomas

Deepa Jagadeesh, MD MPH, Lisa Rybicki, MS, Donna M Abounader, Brian T. Hill, MD PhD, Robert M Dean, MD, Hien K. Duong, MD, Ronald M. Sobecks, MD, Betty K. Hamilton, MD, Aaron Gerds, MDMS, Christina Ferraro, RN, BSN, Gina Green, RN, Kelly Cherni, RN, Brad Pohlman, MD, Matt E. Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS

Blood (2014) 124 (21): 1200.

https://doi.org/10.1182/blood.V124.21.1200.1200

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation for Follicular Lymphoma in the Era of Rutiximab: Cleveland Clinic Experience

Blood (2014) 124 (21): 1201.

https://doi.org/10.1182/blood.V124.21.1201.1201

Published: 2014

Journal Articles

Poor Survival Outcomes In Myelodysplastic Syndrome Patients With Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Influenced By SRSF2 Mutations

Jing Ai, MD, PhD, Valeria Visconte, PhD, Ali Tabarroki, MD, Edy Hasrouni, Betty K. Hamilton, MD, Sudipto Mukherjee, MD, PhD, MPH, Matt Kalaycio, MD, Ronald M. Sobecks, MD, Anjali S. Advani, MD, Mikkael A. Sekeres, MD, MS, Shashirekha Shetty, PhD, Ramon V. Tiu, MD

Blood (2013) 122 (21): 2809.

https://doi.org/10.1182/blood.V122.21.2809.2809

Published: 2013

Journal Articles

Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis

Ali Tabarroki, MD, Daniel Lindner, Valeria Visconte, PhD, Heesun J. Rogers, MD, PhD, John Desamito, Hien K. Duong, MD, Alan E. Lichtin, Anjali S. Advani, MD, Ronald M. Sobecks, MD, Tracy Cinalli, RN, Kristin Dodd, RN, Jing Ai, MD, PhD, Yogen Saunthararajah, M.D., Matt Kalaycio, MD, Brady L. Stein, MD, Mikkael A. Sekeres, MD, MS, Ramon V. Tiu, MD

Blood (2013) 122 (21): 1586.

https://doi.org/10.1182/blood.V122.21.1586.1586

Published: 2013

Journal Articles

Influence Of Killer Immunoglobulin-Like Receptor (KIR) and HLA Genotypes On Outcomes After Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation For Patients With AML and MDS: A Report From The Center For International Blood and Marrow Transplant Research Immunobiology Working Committee

Ronald M. Sobecks, MD, Meighan M. Gallagher, BA, Medhat Askar, MD, PhD, Michael D. Haagenson, MS, Tao Wang, PhD, Stephen Spellman, MBS, Stephanie J. Lee, MD, MPH, Marcelo A. Fernandez Viña, PhD, D(ABHI), Carlheinz R. Muller, MD, PhD, Michael R. Verneris, MD, Ann E. Woolfrey, MD, Peter J. Shaw, MD, Daniel J. Weisdorf, MD, Sarah Cooley, MD, Jeffrey S. Miller, MD, Katharine C. Hsu, MD, PhD

Blood (2013) 122 (21): 159.

https://doi.org/10.1182/blood.V122.21.159.159

Published: 2013

Journal Articles

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Brian Bolwell, MD, Linda McLellan, LISW, Larry Foster, Ph.D, Lisa Rybicki, Ronald M. Sobecks, MD, Brad Pohlman, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Mary Serafin, R.N., Karen Sands, R.N., Jennifer Kosar, R.N., Stacey Brown, Jennifer Bates, Mikkael Sekeres, MD, MS, Jane Dabney, LISW, Erin Welsh, LSW, Matt Kalaycio, MD

Blood (2005) 106 (11): 1322.

https://doi.org/10.1182/blood.V106.11.1322.1322

Published: 2005

Journal Articles

Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin’s Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.

Brian Bolwell, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Steve Andresen, DO, Elizabeth Kuczkowski, Stacey Brown, Jennifer Bates, Lisa Rybicki, Julie Curtis, R.N., Kimberly Bell, R.N., Ronald M. Sobecks, MD

Blood (2005) 106 (11): 2083.

https://doi.org/10.1182/blood.V106.11.2083.2083

Published: 2005

Journal Articles

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Ronald M. Sobecks, MD, Karl S. Theil, MD, Lisa Rybicki, Roger Macklis, MD, Brad Pohlman, MD, Steve Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Kelly Cherni, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Matt Kalaycio, MD, Brian Bolwell, MD

Blood (2005) 106 (11): 3674.

https://doi.org/10.1182/blood.V106.11.3674.3674

Published: 2005

NARROW

Prognostic Parameters in Adults with Acute Lymphoblastic Leukemia at Second Complete Response

Assessment of Human Leukocyte Antigen (HLA) Type on Outcomes of Allogeneic Transplant for Chronic Lymphocytic Leukemia (CLL)

Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide (Bu/Cy/VP) Produces Comparable Outcomes to 4-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)

Prognostic Impact of Molecular Mutations in AML at First Relapse

A Phase I Study of Ixazomib in Combination with Panobinostat and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes: A Center for International Blood and Marrow Transplant Registry (CIBMTR®) Study

Association of Donor Killer Immunoglobulin-like Receptor (KIR) Genotype with Outcome after HLA-Matched Related Donor Hematopoietic Cell Transplantation for AML

A Prognostic Scoring System for Newly Diagnosed Adult Acute Lymphocytic Leukemia Patients

Prognostic Significance of Quality of Life in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Efficacy of Standard Dose R-CHOP Alternating with R-HiDAC Followed By ASCT As Initial Therapy of Mantle Cell Lymphoma: Cleveland Clinic Experience

Long Term Outcomes after Autologous Stem Cell Transplantation for Peripheral T Cell Lymphomas

Autologous Stem Cell Transplantation for Follicular Lymphoma in the Era of Rutiximab: Cleveland Clinic Experience

Poor Survival Outcomes In Myelodysplastic Syndrome Patients With Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Influenced By SRSF2 Mutations

Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis

A Quality of Life Assessment of Ablative Allogeneic Bone Marrow Transplant (BMT) Recipients One and Twelve Months after Transplant.

Autologous Stem Cell Transplantation (ABMT) for Recurrent Hodgkin’s Disease from 1990–2005: Factors Contributing to Post-Transplant Relapse.

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only